Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition Therapeutics is a neuroscience company that is developing oral medications to treat ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Island County authorities have closed the cold case investigation into the 2003 murder of Tamara "Tammy" Mattson in Island ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...